NEXTCELL PHARMA AB revenue breakdown overview

NEXTCELL PHARMA AB revenue for the last year amounted to 1.17 M EUR, the most of which — 935.51 k EUR — came from its highest performing source at the moment, Cell Therapies, the year earlier bringing 847.91 k EUR. The greatest contribution to the revenue figure was made by Sweden — last year it brought NEXTCELL PHARMA AB 935.51 k EUR, and the year before that — 847.91 k EUR.